Cargando…
Covid-19 severe hypoxemic pneumonia: A clinical experience using high-flow nasal oxygen therapy as first-line management
PURPOSE: To report a French experience in patients admitted to Intensive Care Unit (ICU) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requiring high fractional concentration of inspired oxygen supported by high flow nasal cannula (HFNC) as first-line therapy. METHODS: Retrospecti...
Autores principales: | Beduneau, G., Boyer, D., Guitard, P.-G., Gouin, P., Carpentier, D., Grangé, S., Veber, B., Girault, C., Tamion, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175099/ https://www.ncbi.nlm.nih.gov/pubmed/34153702 http://dx.doi.org/10.1016/j.resmer.2021.100834 |
Ejemplares similares
-
High-flow oxygen therapy versus noninvasive ventilation: a randomised physiological crossover study of alveolar recruitment in acute respiratory failure
por: Artaud-Macari, Elise, et al.
Publicado: (2021) -
High flow nasal cannula oxygen therapy in immunocompromised patients with acute hypoxemic respiratory failure
por: Frat, J-P, et al.
Publicado: (2015) -
Skeletal muscle mass and adipose tissue alteration in critically ill patients
por: Dusseaux, Marie Mélody, et al.
Publicado: (2019) -
Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2021) -
High-flow nasal oxygen as first-line therapy for COVID-19-associated hypoxemic respiratory failure: a single-centre historical cohort study
por: Schwartz, Blair Carl, et al.
Publicado: (2022)